STOCK TITAN

Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

DexCom, Inc. (NASDAQ:DXCM) has announced its plans to release its third quarter 2024 financial results after market close on Thursday, October 24, 2024. The company will hold a conference call and webcast to review the Q3 2024 performance starting at 4:30 p.m. Eastern Time on the same day.

Investors and interested parties can access the webcast link on the Dexcom investor relations website at investors.dexcom.com, where it will also be archived for future reference. To participate in the conference call, attendees should dial (877) 344-3040 (US/Canada) or (646) 475-1647 (International) and use the confirmation ID "9430114" approximately five minutes before the start time.

DexCom, Inc. (NASDAQ:DXCM) ha annunciato i suoi piani per rilasciare i risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato giovedì, 24 ottobre 2024. L'azienda terrà una conferenza telefonica e una trasmissione in webcast per rivedere le performance del Q3 2024 a partire dalle 4:30 p.m. ora orientale dello stesso giorno.

Gli investitori e le parti interessate possono accedere al link del webcast sul sito web delle relazioni con gli investitori di Dexcom all'indirizzo investors.dexcom.com, dove sarà anche archiviato per riferimenti futuri. Per partecipare alla conferenza telefonica, i partecipanti devono comporre il numero (877) 344-3040 (US/CANADA) oppure (646) 475-1647 (internazionale) e utilizzare l'ID di conferma "9430114" circa cinque minuti prima dell'orario di inizio.

DexCom, Inc. (NASDAQ:DXCM) ha anunciado sus planes para publicar los resultados financieros del tercer trimestre de 2024 después del cierre del mercado el jueves, 24 de octubre de 2024. La compañía llevará a cabo una conferencia telefónica y un webcast para revisar el rendimiento del Q3 2024 a partir de las 4:30 p.m. hora del Este del mismo día.

Los inversores y partes interesadas pueden acceder al enlace del webcast en el sito web de relaciones con inversionistas de Dexcom en investors.dexcom.com, donde también se archivará para referencia futura. Para participar en la conferencia telefónica, los asistentes deben marcar el (877) 344-3040 (EE. UU./Canadá) o (646) 475-1647 (internacional) y utilizar el ID de confirmación "9430114" aproximadamente cinco minutos antes de la hora de inicio.

DexCom, Inc. (NASDAQ:DXCM)는 2024년 3분기 재무 결과2024년 10월 24일 목요일 시장 마감 후 발표할 계획이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 4시 30분부터 2024년 3분기 실적을 검토하기 위한 전화 회의 및 웹캐스트를 개최할 것입니다.

투자자 및 관심 있는 사람들은 Dexcom 투자자 관계 웹사이트인 investors.dexcom.com에서 웹캐스트 링크에 접속할 수 있으며, 향후 참고를 위해 아카이브될 것입니다. 전화 회의에 참여하려면 참석자는 (877) 344-3040 (미국/캐나다) 또는 (646) 475-1647 (국제)로 전화하고 시작하기 약 5분 전에 확인 ID "9430114"를 사용해야 합니다.

DexCom, Inc. (NASDAQ:DXCM) a annoncé son intention de publier ses résultats financiers du troisième trimestre 2024 après la clôture du marché le jeudi 24 octobre 2024. La société organisera une conférence téléphonique et un webcast pour examiner la performance du T3 2024 à partir de 16h30, heure de l'Est le même jour.

Les investisseurs et les parties intéressées peuvent accéder au lien du webcast sur le site web des relations investisseurs de Dexcom à l'adresse investors.dexcom.com, où il sera également archivé pour référence future. Pour participer à la conférence téléphonique, les participants doivent composer le (877) 344-3040 (États-Unis/Canada) ou le (646) 475-1647 (international) et utiliser l'ID de confirmation "9430114" environ cinq minutes avant l'heure de début.

DexCom, Inc. (NASDAQ:DXCM) hat angekündigt, dass die Finanzergebnisse für das dritte Quartal 2024 nach Börsenschluss am Donnerstag, den 24. Oktober 2024 veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Leistung des Q3 2024 zu überprüfen.

Investoren und interessierte Parteien können den Webcast-Link auf der Investor-Relations-Website von Dexcom unter investors.dexcom.com aufrufen, wo er auch für zukünftige Referenzen archiviert wird. Um an der Telefonkonferenz teilzunehmen, sollten die Teilnehmer (877) 344-3040 (US/Kanada) oder (646) 475-1647 (international) wählen und ungefähr fünf Minuten vor Beginn die Bestätigungs-ID "9430114" nutzen.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2024 financial results after market close on Thursday, October 24, 2024. Management will hold a conference call to review the company's third quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.

To listen to the conference call, please dial (877) 344-3040 (US/Canada) or (646) 475-1647 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

Category: IR

DexCom, Inc.:

Sean Christensen

Vice President – Finance and Investor Relations

investor-relations@dexcom.com

(858) 200-0200

Source: DexCom, Inc.

FAQ

When will Dexcom (DXCM) release its Q3 2024 financial results?

Dexcom (DXCM) will release its third quarter 2024 financial results after market close on Thursday, October 24, 2024.

What time is Dexcom's (DXCM) Q3 2024 earnings conference call?

Dexcom's (DXCM) Q3 2024 earnings conference call is scheduled for 4:30 p.m. Eastern Time on Thursday, October 24, 2024.

How can I access Dexcom's (DXCM) Q3 2024 earnings call?

You can access Dexcom's (DXCM) Q3 2024 earnings call by dialing (877) 344-3040 (US/Canada) or (646) 475-1647 (International) and using the confirmation ID '9430114'. A webcast will also be available on the Dexcom investor relations website.

Where can I find the webcast for Dexcom's (DXCM) Q3 2024 earnings call?

The webcast for Dexcom's (DXCM) Q3 2024 earnings call will be available on the Dexcom investor relations website at investors.dexcom.com.

DexCom, Inc.

NASDAQ:DXCM

DXCM Rankings

DXCM Latest News

DXCM Stock Data

27.61B
400.73M
0.32%
100.93%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO